Cellectar Biosciences, Inc. — Director's Dealing 2015

Aug 6, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2015-06-15

Reporting Person: Loren Stefan (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$2.64	2025-06-15	Common Stock (10000)		Direct

Footnotes

F1: Option vests in equal quarterly increments over a period of three years from the date of grant. Option expires on the tenth anniversary of the date of grant.